F-star bags third Takeda tie-up in a year with multi-specific antibodies for cancer
The stars have aligned for the third time between invoX Pharma’s F-star and Takeda as the duo gets to work on another antibody pact, with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
